AM-2389
Izgled
(IUPAC) ime | |||
---|---|---|---|
(6aR,9R,10aR)-3-(1-heksil-ciklobut-1-il)-6a,7,8,9,10,10a-heksahidro-6,6-dimetil-6H-dibenzo[b,d]piran-1,9 diol | |||
Klinički podaci | |||
Identifikatori | |||
CAS broj | 1256842-49-5 | ||
ATC kod | ? | ||
PubChem[1][2] | 49783410 | ||
ChemSpider[3] | 26333264 | ||
Hemijski podaci | |||
Formula | C25H38O3 | ||
Mol. masa | 386,566 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status |
AM-2389 je klasični kanabinoidni derivat koji deluje kao potentan i relativno selektivan agonist za CB1 receptora, sa Ki od 0,16 nM, i 26x selektivnošću u odnosu na srodni CB2 receptor. On ima visoku potentnost na životinjskim testovima kanabinoidne aktivnosti, i umerenu dužinu trajanja.[4][5].
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Nikas SP, et al. Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist. Journal of Medicinal Chemistry. 2010 Oct 14;53(19):6996-7010. PMID 20925434
- ↑ Järbe TU, et al. AM2389, a high-affinity, in vivo potent CB(1)-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice. Psychopharmacology (Berlin). 2011 Oct 12. PMID 21989802